Endometrial Stromal Sarcoma
Symptoms, Doctors, Treatments, Advances & More

Endometrial Stromal Sarcoma Overview

Save information for later
Sign Up

Learn About Endometrial Stromal Sarcoma

What is the definition of Endometrial Stromal Sarcoma?
Endometrial stromal sarcoma is a rare form of cancer that occurs due to abnormal and uncontrolled cell growth in the uterus. Endometrial stromal sarcoma, specifically, develops in the supporting connective tissue (stroma) of the uterus. Signs and symptoms of the condition include abnormal uterine bleeding (i.e. bleeding that is not part of menstrual periods or bleeding after menopause); abdominal pain and/or distension; and frequent urination. The exact underlying cause of Endometrial stromal sarcoma is currently unknown. Most cases occur sporadically in people with no family history of the condition.
What are the alternative names for Endometrial Stromal Sarcoma?
  • Endometrial stromal sarcoma
  • ESS
Who are the top Endometrial Stromal Sarcoma Local Doctors?
Elite in Endometrial Stromal Sarcoma
Dr. Mario M. Leitao
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Elite in Endometrial Stromal Sarcoma
Dr. Mario M. Leitao
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Referral may be required

Rockefeller Outpatient Pavilion

160 E 53rd St, 
New York, NY 
914-229-2473
Languages Spoken:
English, Portuguese, Spanish
See accepted insurances
Accepting New Patients

Mario Leitao is a Gynecologic Oncologist and an Oncologist practicing medicine in New York, New York. Dr. Leitao is rated as an Elite provider by MediFind in the treatment of Endometrial Stromal Sarcoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vulvar Cancer, Vaginal Cancer, Hysterectomy, and Lymphadenectomy. Dr. Leitao is currently accepting new patients.

Distinguished in Endometrial Stromal Sarcoma
Dr. Edward J. Tanner-Iii
Oncology | Obstetrics and Gynecology
Distinguished in Endometrial Stromal Sarcoma
Dr. Edward J. Tanner-Iii
Oncology | Obstetrics and Gynecology
Referral may be required

Sibley Memorial Hospital

5275 Loughboro Road Northwest, Building D, 
Washington, DC 
202-243-5295
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Edward Tanner-Iii is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Washington, Washington, D.c.. Dr. Tanner-Iii is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy. Dr. Tanner-Iii is board certified in American Board Of Obstetrics And Gynecology. Dr. Tanner-Iii is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Endometrial Stromal Sarcoma
Dr. Wei-chien M. Lin
Oncology | Obstetrics and Gynecology
Distinguished in Endometrial Stromal Sarcoma
Dr. Wei-chien M. Lin
Oncology | Obstetrics and Gynecology
Referral may be required

Wei-Chien M. Lin, MD Private Practice

15031 Rinaldi St., Ste 150, 
Mission Hills, CA 
818-660-4700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Wei-chien Lin is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Mission Hills, California. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Cervical Cancer, Oophorectomy, and Salpingo-Oophorectomy. Dr. Lin is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology. Dr. Lin is currently accepting new patients.

View All Doctors
What are the latest Endometrial Stromal Sarcoma Clinical Trials?
A Phase 2 Study Evaluating the Efficacy of Elacestrant in Patients With Estrogen Receptor Positive Uterine Sarcomas
A Phase 2 Study Evaluating the Efficacy of Elacestrant in Patients With Estrogen Receptor Positive Uterine Sarcomas
Enrollment Status: Recruiting
Publish Date: May 22, 2026
Intervention Type: Drug
Study Phase: Phase 2

Summary: This study is to evaluate the efficacy and safety of elacestrant, in participants with advanced estrogen receptor (ER)-positive uterine sarcomas. The name of the study drug involved in this research study is: -Elacestrant (a type of selective estrogen receptor degrader)

Match to trials
Find the right clinical trials for you in under a minute
Get started
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
Who is this study for: Patients with Low Grade Endometrial Stromal Sarcoma
Enrollment Status: Recruiting
Publish Date: February 17, 2026
Intervention Type: Drug
Study Drug: Aromatase Inhibitors
Study Phase: Phase 2

Summary: The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center